Could neonatal disseminated herpes simplex virus infections be treated earlier?

The Journal of Infection
Katy J FidlerMark J Peters

Abstract

Neonatal disseminated herpes simplex virus (HSV) infection can cause rapidly progressive multiple organ failure with an 85% mortality if untreated. Early recognition and treatment may improve outcome [N Engl J Med 324(1991)450]. (i) To determine the number and presentation of neonates with disseminated HSV admitted to an intensive care unit. (ii) To determine paediatric Specialist Registrar (SpR) awareness of the diagnosis and management of a typical potential case of neonatal disseminated HSV. (i) A 10-year review of case notes of neonates admitted to the intensive care unit (ICU) at Great Ormond Street Hospital. (ii) A telephone questionnaire of 'on-call' Paediatric SpR's in the London area. Eight cases of confirmed disseminated HSV infection were identified. All died. Each case followed a similar clinical course with presentation between days 5-9 of life (median day 7). A short prodrome preceded the rapid development of disseminated intravascular coagulopathy (DIC), hepatitis and multiple organ failure. Only three cases received antiviral treatment in the first 24 h after hospital admission. None of the 30 registrars who were interviewed initially considered disseminated HSV in the differential diagnosis of a 7-day-old baby ...Continue Reading

Citations

Jan 13, 2006·Medical Microbiology and Immunology·Astrid MeerbachPeter Wutzler
Feb 27, 2009·Pediatric Emergency Care·Kara L DavisStephen C Eppes
Jul 22, 2008·Journal of Paediatrics and Child Health·Ashley FordAvinash K Shetty
Jan 1, 2011·BMJ Case Reports·Lucy Anne FitzgeraldStanley Zengeya
May 8, 2007·Emerging Infectious Diseases·Aleksandra KnezevicTanja Jovanovic
Apr 11, 2014·Iranian Red Crescent Medical Journal·Saeid Amel JamehdarMohammad Hassan Aelami
Apr 1, 2012·Journal of Clinical Neonatology·Said D AbuhasnaKhalid H Atwa
May 3, 2011·The Journal of Pediatrics·Katherine E McGooganRegino P González Peralta
Mar 1, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·R N GunsonC Aitken
Mar 11, 2016·The Journal of Pediatrics·Alison L CurfmanAaron S Miller
Oct 10, 2015·Clinical Pediatrics·Shimrit Tzvi-BehrOrli Megged
Dec 2, 2009·The American Journal of Forensic Medicine and Pathology·Daniel W Dye, Gary T Simmons
Apr 28, 2007·Scandinavian Journal of Infectious Diseases·Carl-Johan TörnhageTomas Bergström
Apr 21, 2020·The American Journal of Dermatopathology·Elizabeth O Silloca Cabana, Anna G McDonald
Jan 2, 2021·Molecular Diagnosis & Therapy·Wei Zhen, Gregory J Berry
Mar 30, 2019·Pediatrics·James Gaensbauer, Joseph A Grubenhoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Seminars in Fetal & Neonatal Medicine
G Malm
Pediatrics
David W KimberlinNational Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
Pediatrics
David W KimberlinNational Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group
Seminars in Pediatric Infectious Diseases
David W Kimberlin, Richard J Whitley
© 2022 Meta ULC. All rights reserved